Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency

M Walter1, S Kerber, C Fechtrup

  • 1Institut für Klinische Chemie und Laboratoriumsmedizin, Westfälische Wilhelms-Universität Münster, FRG.

Atherosclerosis
|October 1, 1994
PubMed

Insights

This study examined a patient with Tangier disease, a condition marked by low HDL cholesterol. Despite this, the patient showed no severe atherosclerosis, challenging the assumption that HDL deficiency accelerates arterial disease.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Genetics

Background:

  • Familial HDL deficiency, or Tangier disease, is characterized by extremely low levels of high-density lipoprotein (HDL) cholesterol.
  • This condition is associated with massive foam cell accumulation in various tissues.
  • The impact of severe HDL deficiency on atherosclerosis development remains incompletely understood.

Observation:

  • A 60-year-old homozygous patient with Tangier disease presented with chest pain.
  • Coronary angiography and intravascular ultrasound were performed to assess cardiovascular status.
  • Left ventricular function was normal, with diffuse coronary sclerosis but no critical stenosis.

Findings:

  • Intravascular ultrasound showed normal arterial wall structure without significant atherosclerotic plaques, intimal hyperplasia, or calcification.
  • Only a single, discrete atherosclerotic lesion was noted in one iliac artery segment.
  • Contrary to expectations, severe atherosclerosis was not observed despite the patient's known HDL deficiency and foam cell formation.

Implications:

  • These findings suggest that severe HDL deficiency and foam cell formation in Tangier disease may not invariably lead to accelerated or severe atherosclerosis.
  • Further research is needed to elucidate the complex interplay between HDL levels, lipid metabolism, and atherogenesis in rare genetic disorders.
  • This case highlights the potential for cardiovascular health despite profound lipid abnormalities, prompting a re-evaluation of atherosclerosis risk factors.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...